Dissertationsthema:
"LONG-TERM FOLLOW-UP OF PATIENTS AFTER ACUTE PULMONARY EMBOLISM
A Holistic Strategy Integrating Clinical, Hemodynamic and Laboratory Parameters with Patient-Reported Outcomes"
(FB 04: Universitätsmedizin, Center for Thrombosis and Hemostasis, Multicenter Clinical Trials, Prof. Dr. Stavros Konstantinides)
Wissenschaftlicher Werdegang
Seit 2020
PhD, Center for Thrombosis and Hemostasis, Johannes Gutenberg-Universität Mainz
2020 – 2022
M.Sc. in Epidemiology, Johannes Gutenberg-Universität Mainz
2018 – 2020
M.Sc. in Nanosciences & Nanotechnologies, Aristotle University of Thessaloniki, Griechenland
2012 – 2018
Medical Diploma, Aristotle University of Thessaloniki, Griechenland
Erasmus-Aufenthalte
2018
Center for Thrombosis and Hemostasis, Universitätsmedizin Mainz
2017 – 2018
RWTH Universität Aachen
2017
Klinikum Coburg
2016
University of Bergen, Norwegen
Ausgewählte Publikationen
Farmakis IT, Barco S, Mavromanoli AC, Konstantinides SV, Valerio L. Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism: Insights from the Hokusai-VTE Cancer Study. JACC: CardioOncology. 2022; 4 (4): 507-518.
Bougioukas KI, Diakonidis T, Mavromanoli AC, Haidich AB. ccaR: a package for assessing primary study overlap across systematic reviews in overviews. Res Synth Methods. 2022 Nov 12.
Farmakis IT, Barco S, Mavromanoli AC, Agnelli G, Cohen AT, Giannakoulas G, Mahan CE, Konstantinides SV, Valerio L. Cost-of-Illness Analysis of Long-Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry. J Am Heart Assoc. 2022 Oct 17:e027514.
Farmakis IT, Barco S, Hobohm L, Braekkan SK, Connors JM, Giannakoulas G, Hunt BJ, Keller K, Mavromanoli AC, Trinchero A, Konstantinides SV, Valerio L. Maternal mortality related to pulmonary embolism in the United States, 2003-2020. Am J Obstet Gynecol MFM. 2022 Sep 22:100754.
Hobohm L, Farmakis IT, Keller K, Scibior B, Mavromanoli AC, Sagoschen I, Münzel T, Ahrens I, Konstantinides S. Pulmonary embolism response team (PERT) implementation and its clinical value across countries: a scoping review and meta-analysis. Clin Res Cardiol. 2022 Aug 17.
Valerio L, Mavromanoli AC, Barco S, Abele C, Becker D, Bruch L, Ewert R, Faehling M, Fistera D, Gerhardt F, Ghofrani HA, Grgic A, Grünig E, Halank M, Held M, Hobohm L, Hoeper MM, Klok FA, Lankeit M, Leuchte HH, Martin N, Mayer E, Meyer FJ, Neurohr C, Opitz C, Schmidt KH, Seyfarth HJ, Wachter R, Wilkens H, Wild PS, Konstantinides SV, Rosenkranz S; FOCUS Investigators. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study. Eur Heart J. 2022 Apr 28:ehac206.
Konstantinides S, Mavromanoli A, Hobohm L. COVID-19 und Thrombosen. Kardiologie up2date. 2022; 18 (1): 65–86.
Konstantinides S, Mavromanoli A, Hobohm L. Diagnostik und Therapie der Lungenembolie. Herz. 2021.
Klok FA, Toenges G, Mavromanoli AC, Barco S, Ageno W, Bouvaist H, Brodmann M, Cuccia C, Couturaud F, Dellas C, Dimopoulos K, Duerschmied D, Empen K, Faggiano P, Ferrari E, Galiè N, Galvani M, Ghuysen A, Giannakoulas G, Huisman MV, Jiménez D, Kozak M, Lang IM, Lankeit M, Meneveau N, Münzel T, Palazzini M, Petris AO, Piovaccari G, Salvi A, Schellong S, Schmidt KH, Verschuren F, Schmidtmann I, Meyer G, Konstantinides SV; PEITHO-2 investigators. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial. Lancet Haematol. 2021:S2352-3026(21)00203-9.
Mavromanoli AC, Barco S, Konstantinides SV. Antithrombotics and new interventions for venous thromboembolism: Exploring possibilities beyond factor IIa and factor Xa inhibition. Res Pract Thromb Haemost. 2021;5(4):rth2.12509.